Literature DB >> 14723835

Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.

Virmeet V. Singh1, Phillip P. Toskes.   

Abstract

Small bowel bacterial overgrowth (SBBO) syndrome is associated with excessive numbers of bacteria in the proximal small intestine. The pathology of this condition involves competition between the bacteria and the human host for ingested nutrients. This competition leads to intraluminal bacterial catabolism of nutrients, often with production of toxic metabolites and injury to the enterocyte. A complex array of clinical symptoms ensues, resulting in chronic diarrhea, steatorrhea, macrocytic anemia, weight loss, and less commonly, protein-losing enteropathy. Therapy is targeted at correction of underlying small bowel abnormalities that predispose to SBBO and appropriate antibiotic therapy. The symptoms and signs of SBBO can be reversed with this approach.

Entities:  

Year:  2004        PMID: 14723835     DOI: 10.1007/s11938-004-0022-4

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  56 in total

1.  Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome.

Authors:  Y Bouhnik; S Alain; A Attar; B Flourié; L Raskine; M J Sanson-Le Pors; J C Rambaud
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

2.  Small intestinal bacterial overgrowth is associated with irritable bowel syndrome: the cart lands squarely in front of the horse.

Authors:  M P Jones; R Craig; E Olinger
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

Review 3.  Gastrointestinal manifestations of scleroderma.

Authors:  S Rose; M A Young; J C Reynolds
Journal:  Gastroenterol Clin North Am       Date:  1998-09       Impact factor: 3.806

4.  Small intestinal bacterial overgrowth in patients with chronic lymphocytic leukaemia.

Authors:  G M Smith; I M Chesner; P Asquith; M J Leyland
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

5.  Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial.

Authors:  A Attar; B Flourié; J C Rambaud; C Franchisseur; P Ruszniewski; Y Bouhnik
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

Review 6.  Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation.

Authors:  Joseph Romagnuolo; Dan Schiller; Robert J Bailey
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

7.  Small intestinal bacterial overgrowth in the symptomatic elderly.

Authors:  S M Riordan; C J McIver; D Wakefield; T D Bolin; V M Duncombe; M C Thomas
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

8.  Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia.

Authors:  Tilman M Bauer; Henning Schwacha; Bernhard Steinbrückner; Folke E Brinkmann; Anette K Ditzen; John J Aponte; Klaus Pelz; Dieter Berger; Manfred Kist; Hubert E Blum
Journal:  Am J Gastroenterol       Date:  2002-09       Impact factor: 10.864

9.  Altered myoelectric activity in the experimental blind loop syndrome.

Authors:  P G Justus; A Fernandez; J L Martin; C E King; P P Toskes; J R Mathias
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

10.  Small bowel bacterial overgrowth in patients with alcoholic cirrhosis.

Authors:  F C Morencos; G de las Heras Castaño; L Martín Ramos; M J López Arias; F Ledesma; F Pons Romero
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

View more
  20 in total

1.  Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease.

Authors:  Alberto Rubio-Tapia; Susan H Barton; Jon E Rosenblatt; Joseph A Murray
Journal:  J Clin Gastroenterol       Date:  2009-02       Impact factor: 3.062

2.  Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.

Authors:  Amit H Sachdev; Mark Pimentel
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

3.  Functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Therapy       Date:  2011-05-01

Review 4.  Uncommon Diverticular Disease.

Authors:  Sanjay Mohanty; Shawn P Webb
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

5.  Antibiotics for the treatment of irritable bowel syndrome.

Authors:  Robert J Basseri; Stacy Weitsman; Gillian M Barlow; Mark Pimentel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-07

Review 6.  Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.

Authors:  Giulia Malaguarnera; Maria Giordano; Giuseppe Nunnari; Gaetano Bertino; Michele Malaguarnera
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 7.  Diarrhoea due to small bowel diseases.

Authors:  Joseph A Murray; Alberto Rubio-Tapia
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-10       Impact factor: 3.043

8.  Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Authors:  Savio C Reddymasu; Sandra Sostarich; Richard W McCallum
Journal:  BMC Gastroenterol       Date:  2010-02-22       Impact factor: 3.067

Review 9.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

10.  Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS.

Authors:  Janet Yang; Hyo-Rang Lee; Kimberly Low; Soumya Chatterjee; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2007-05-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.